CD22 and breast carcinoma: When CD22 expression was investigated in breast cancer by Gene Expression Profiling Interactive Analysis (GEPIA) online database, the level of CD22 expression was slightly higher in breast cancer tissues than that in normal tissues (Figure 1B).